GW Adds US IR Exec Ahead of IPO
Wed., Mar. 20, 2013
By Greg Hazley
GW Pharmaceuticals, the English drug maker planning a U.S. initial public offering, is working with outside communications counsel and hired a U.S.-based PR and investor relations exec.
Read Full Story in Subscriber Area
Category: Financial PR & Investor Relations
More Financial PR & Investor Relations posts from O'Dwyer's:
• | FGS Global Works Thoma Bravo's Cyber AI DealFri., Apr. 26, 2024 |
• | 2023 Was 'Mixed Bag' for Financial PR FirmsFri., Apr. 26, 2024 |
• | Edelman Sails with VikingMon., Apr. 22, 2024 |
• | Teneo Handles CVC Capital’s IPOMon., Apr. 15, 2024 |
• | Brunswick, Edelman Smithfield Work Endeavor’s $13B DealWed., Apr. 3, 2024 |
No comments have been submitted for this story yet.